The Tests That Could Save Your Life

Heart disease remains the number one killer globally, and India bears a disproportionate burden — Indians develop coronary artery disease a full decade earlier than Western populations and have a higher case-fatality rate. Yet the standard cardiac evaluation — blood pressure, basic lipid panel, and perhaps a treadmill stress test — catches only a fraction of those at risk.

The uncomfortable truth? The first symptom of heart disease is a heart attack in approximately 50% of cases. If we want to prevent rather than react, we need tests that detect the disease process years or decades before catastrophic events.

Beyond the Basic Lipid Panel

ApoB (Apolipoprotein B): As we have discussed elsewhere, ApoB counts every atherogenic particle in your blood — not just the cholesterol they carry. It is a superior predictor of cardiovascular events compared to LDL-C. Longevity target: below 60 mg/dL.

Lipoprotein(a) [Lp(a)]: This is a genetically determined lipoprotein particle that dramatically increases cardiovascular and aortic valve disease risk. Approximately 20% of the global population has elevated Lp(a), and you cannot change it through diet or exercise. It is largely genetically fixed, which means it only needs to be measured once — but that one measurement can be life-altering. Yet most doctors never order it.

A 2022 European Heart Journal consensus statement recommended Lp(a) measurement in all adults at least once in their lifetime, as levels above 50 mg/dL (or 125 nmol/L) significantly increase cardiovascular risk.

CIMT (Carotid Intima-Media Thickness): This ultrasound measurement of the carotid artery wall thickness directly visualizes early atherosclerosis. It is non-invasive, inexpensive, and provides structural evidence of vascular aging that blood tests cannot.

Coronary Artery Calcium (CAC) Score: A low-dose CT scan that quantifies calcified plaque in the coronary arteries. A CAC score of zero is powerfully reassuring — it indicates very low 10-year cardiovascular event risk. A non-zero score, conversely, provides motivation and guidance for aggressive risk factor management. The 2019 ACC/AHA guidelines endorse CAC scoring for risk stratification in intermediate-risk patients.

Inflammatory and Metabolic Markers

hs-CRP: Inflammation drives plaque instability. An hs-CRP above 1.0 mg/L adds independent risk information beyond lipid levels.

Homocysteine: Elevated homocysteine damages the vascular endothelium and promotes thrombosis. Levels above 10 μmol/L warrant attention, and correction with B vitamins is straightforward when identified.

Fasting insulin and HOMA-IR: Insulin resistance is a powerful driver of atherosclerosis — often years before glucose levels become abnormal. These markers bridge the gap between metabolic and cardiovascular risk assessment.

Functional Testing

VO2 max testing: Cardiorespiratory fitness is the strongest predictor of cardiovascular mortality. A VO2 max test quantifies your fitness level with precision and guides exercise prescriptions that actually move the needle on heart health.

Building a Complete Picture

No single test is sufficient. Cardiovascular risk assessment should integrate advanced lipid testing, inflammatory markers, metabolic assessment, structural imaging, and functional fitness evaluation. Together, these create a comprehensive picture that standard screening cannot match.

At GenoRyx, our cardiovascular risk assessment goes far beyond the routine checkup. Book a consultation to discover what your heart health truly looks like — not just whether you have crossed a disease threshold.